https://www.theedgemarkets.com/article/penny-stocks-top-bursa-active-list-retail-players-go-after-them

All those penny stock announcements, non has come true yet. So be wise.

as said, be fast to take profit before the shark eat you up. greedy is the failure of all investment.

as for the reputable china drug company, do you think he will sign with small cap company for the major distribution, furthermoew it need KKM ( government) approval for any vaccine deal. it is country to country issue, beware of MOU that is just a paper.

Before the big shark eat you, better take profit and run.

Just like AT is always doing, many died

the announcement is only intention and carry no water.

Don't blind blind go in, solution has no facility and you must know vaccine need KKM license and not only MoU can solve. Beware of trap. The MoU is 1 year period with no commitment. Study first before investing

Government paid ? Better price due to negoti

https://www.theedgemarkets.com/article/duopharma-shopee-expect-increasing-demand-vitamin-c-amid-covid19

high revenue but getting lower profit, something is not right in the management. beware.

hit limit up already... wait for tomorow show.

luckily I top up a lot at 3.0..... believe in yourself. don listen to nonsense around you.

OMG !! is crossing the 200 MA already

Higher high is coming, hold tight and believe in yourself.

hold and it is second wave to rally.

吉隆坡17日讯）顶级手套（TOPGLOV，7113，主板医疗保健）股价近期陷入盘整，这厢散户吓得急脱手，那厢创办人兼执行主席丹斯里林伟才却趁低进场，直接以行动展现对公司的信心！



顶级手套股价从早前每股29.30令吉的新高，近日跌至22令吉左右水平，跌幅达25%。截至今日闭市，顶级手套挂22.42令吉，跌1.40令吉，成交量达2722万3000股。

但根据马证交所的主要股东股权变动通知，林伟才上周趁股价下跌进场吸购，过去两个交易日共大举买进92万8800股股票。

it is a good sign of rebound..

apa sudah jadi ??

the "V" shape is forming.

managed to sapo lots at 3.05

the buying is back now, lets relax.

https://www.cnn.com/2020/08/12/asia/herd-immunity-coronavirus-india-intl-hnk-dst/index.html

MQ is mainly semiconductor line and tools, don't relate with the health care. It should bounce tomorrow since corrections already reached the end. Good show

Is time to buy now when many are panic sell. Good opportunity!

MQ will rebound after today correction

time to collect low ticket liao...hahaha

time to add low ticket already !

time to buy, ... buy when people panic.

Sure genuine news ?

just hold tight ! we know is coming.... don get influence from negative people. it is investment , not gambling.

profit taking should end soon, wait for rebound.

neymar, how sure are you, if drop , u pay ?

any idea what announcement ?

Market Capital (RM) 1.971b
Number of Share 684.38m
EPS (cent)* 7.94
P/E Ratio 36.27
ROE (%) 10.05
Dividend (cent)^ 6.000

That's great enough for buy call

http://www.ecns.cn/news/sci-tech/2020-08-07/detail-ifzyxfhw7469699.shtml

世卫卫生紧急项目负责人迈克尔·瑞安表示，目前全球约有165种疫苗处于试验阶段，26种进入临床试验阶段，6种已处于三期临床试验阶段，短期内取得如此成果是难以置信。接下来就是要确保疫苗安全有效，三期临床试验将展开大规模测试，世卫组织希望将有更多候选疫苗进入三期临床试验阶段。

Pharma will be reporting coming 2nd Quarter QR and insider projection is expecting it to burst into some very good figure. Expected date for result is 18/19 AUGUST 2020!!

Since Pharma contract to supply to Malaysian government is extended to the end of December 2021, we expect that the COVID-19 preparation and the medical supplies stock up as well as enhance usage of gloves, face shield, face mask and hand sanitizer will increase drastically.

Don't forget PHARMA also have INDONESIA operation, so the effect will be much more stronger!!! MORE SALES, MORE REVENUE, MORE PROFIT!!

So in short, without the VACCINE coming in, PHARMA will still be reporting very excellent result for Q2 and that is for sure..

NEW YORK (Aug 5): Novavax Inc shares touched a five-year high as investors assessed early data on its experimental vaccine for Covid-19.

The stock surged as much as 21%, after sinking in extended trading yesterday. Novavax has rallied more than 4,300% so far this year on speculation about the potential for its vaccine.

Results presented yesterday evening from a two-injection regimen when administered concurrently with Novavax's immune-boosting technology generated antibody responses that were four times higher than those seen in people who had recovered from the disease. Some of the healthy adults in the study experienced side effects including fever, headache, and fatigue.

Profit taking process be patient

8888, u jump first

Easily RM 4 this month, just keep.

Halal is just a process issue, just like use of alcohol in medication. No problem at all.

EPF already pumped in a lot this few day, show is coming.

KUALA LUMPUR (July 15): MQ Technology Bhd (MQTech) has inked an investment and collaboration joint venture (JV) agreement with Hong Kong-based JD Resources International Ltd to acquire a company that is involved in the manufacturing and marketing of gloves and possesses a glove-making factory.

To recap, last month MQTech hogged the limelight following a news report published by The New Straits Times that it was a front runner, alongside Top Glove Corp Bhd, to acquire glove manufacturer Latexx Partners.

In a statement today, MQTech said its unit Microlead Manufacturing Sdn Bhd inked the deal with JD to expand their businesses and jointly cooperate to acquire the glove company, which it did not name, via the JV.

it should break the Jun high and reach 0.18 by next week.

Coronavirus vaccines are rapidly advancing through the development pipeline. The University of Oxford’s vaccine is in large trials in Britain, Brazil and South Africa. In the United States, researchers just began enrolling around 30,000 volunteers to test Moderna’s vaccine, and more trials are starting every day. Operation Warp Speed has set an ambitious goal of delivering 300 million doses of a safe, effective vaccine by January.

Moving up in steady mode already

Both of these vaccines (from Moderna and Oxford University/Astra Zeneca) have already been shown, in phase 1 trials, to be safe and probably effective. That’s why the companies are moving ahead and giving each vaccine to 30,000 more people: they are fairly confident that the vaccines are safe. The NY Times reports that 3 other Covid-19 vaccines are also in phase 3 trials: one from BioNTech and Pfizer, and two from Chinese companies, Sinopharm and Sinova Biotech.

https://www.fool.com/investing/2020/08/02/3-reasons-to-buy-moderna-now.aspx

NEW YORK (July 29): Shares of Eastman Kodak Co have leapt 2,441% higher this week, sending its market valuation to nearly US$2 billion, after it won a government loan to help produce ingredients used in key generic medicines to fight the coronavirus.